Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) has a higher price-to-earnings ratio of 103.55x compared to its average ratio, The 36-month beta value for BMRN is at
Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) has a higher price-to-earnings ratio of 99.61x compared to its average ratio. BMRN has 36-month beta value of 0.32. Analysts
Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) has a higher price-to-earnings ratio of 96.54x compared to its average ratio. BMRN has 36-month beta value of 0.31. Analysts
© 2024, Fueled by Smart TechOne
